Pharma Pulse 4/15/24: Increase in ransomware attacks to healthcare's remote access systems, The Health and Healthcare of Gen Xers & more
The latest news for pharma industry insiders.
Pharma Pulse 4/12/24: The Road Ahead for GenAI-Enabled/Augmented Clinical Trials, The Health and Healthcare of Boomers & more
Pharma Pulse 4/11/24: In Battle Over Health Care Costs, Private Equity Plays Both Sides, Psychedelic Medicine Could Fill Care Gap & more
Pharma Pulse 4/10/24: 7% of Patients with Cancer Participate in Research, Technologies Being Used to Enhance Trial Enrollment and Diversity & more
Pharma Pulse 4/9/24: AI in Clinical Development, Patient Preferences Play Essential Part in Contraceptive Care & more
Pharma Pulse 4/8/24: Cannabis Use in Oncology, J&J to Acquire Shockwave Medical & more
Pharma Pulse 4/5/24: Is 2024 the Year for Psychedelic Medicine? Barriers Impacting Enrollment in Lung Cancer Trials & more
Pharma Pulse 4/4/24: Baltimore Bridge Collapse Upends US Supply Chains, Can Employees Realistically Expect Any Good Jobs for 2024? & more
Pharma Pulse 4/3/24: Trends Shaping the Future of Drug Development, Pharmacists Can Help Monitor Cardiometabolic Parameters in Schizophrenia & more
Pharma Pulse 4/2/24: Tackling Barriers to Adopting BYOD, Lonely Men with HIV More Likely to Smoke & more
Pharma Pulse 4/1/24: Uncertainties Associated with Accelerated Approval, Understanding DSCSA & more
Pharma Pulse 3/29/24: Social Media Users Turn to Twitter for Guidance on Birth Control, Wider Availability of Oral Contraceptives & more
Pharma Pulse 3/28/24: Do Mixed Results Impact Potential Real-World Effectiveness? FDA Issues Letters Over Unapproved, Misbranded OTC Analgesic Products & more
Pharma Pulse 3/27/24: What's the ROI on GenAI? Virtual Second Opinions Save Over $8,700 Per Patient & more
Pharma Pulse 3/26/24: Medicare to Cover Wegovy, US-China Decoupling Poses Supply Chain Risks & more
Pharma Pulse 3/25/24: The Intersection of AI & Marketing, Birth Control to Be Sold OTC & more
Pharma Pulse 3/22/24: More Studies by Columbia Cancer Researches Retracted, Vista.ai Appoints MedTech Veteran as CEO & more
Pharma Pulse 3/21/24: Should Copay Accumulators be Banned? Pharmatizing AI & more
Pharma Pulse 3/20/24: The DSCSA and the New Importation Policy in Florida, How Secure IS an Airplane’s Wi-Fi? & more
Pharma Pulse 3/19/24: AI’s Impact on CEO/Founder Sustainability, Practical Strategies to Repel Cyber Attacks & more
Pharma Pulse 3/18/24: Weight-Loss Drug Through Amazon, Overcoming Gender Inequities in Health Care & more
Pharma Pulse 3/15/24: Elranatamab Maintains or Improves Symptoms of Multiple Myeloma Patients, AI Assistant for Security Products & more
Pharma Pulse 3/14/24: Celebrity Endorsements in Ozempic, Enhancing Transparency Between Patients and Researchers & more
Pharma Pulse 3/13/24: Navigating the Mental Health Challenges of Cancer, Putting Menopause Medication on the Main Stage & more
Pharma Pulse 3/11/24: Yogurt May Reduce Diabetes Risk, Tech Evangelist's Dreams for AI Tutors Might be Too Big & more
Pharma Pulse 3/8/24: Lilly's New Campaign Challenges Misperceptions About Obesity Care, Challenges Facing Broader Adoption of Novel Cell and Gene Therapies & more
Pharma Pulse 3/7/24: Rite Aid Enters into APA, S.E.C. Investigates OpenAI & more
Pharma Pule 3/6/24: Air Pollution Linked to Childhood Asthma, Four-Steps to Accelerate Study Start-up Cycles & more
Pharma Pulse 3/5/24: How the Pandemic Changed the Way Pharma Looks at Data Integrity in 2024, ow Your Protein Needs Change as You Age & more
Pharma Pulse 3/4/24: Local Pharmacies on the Brink, People in MA Plans Experienced Delays in Accessing Care & more
